Contract Research & Services

Biomarkers: Key to Better Rheumatoid Arthritis Drug Development and Treatment

Published 27 May 2015 | By Quintiles

Rheumatoid arthritis (RA) affects approximately 1% of the world’s population with an ever-increasing burden on health, quality of life and the economy.

Available Downloads

Biomarkers: Key to Better Rheumatoid Arthritis Drug Development and Treatment